Open AccessCharacteristics of Copayment Offsets for Prescription Drugs in the United States
Author(s) -
Aditi P. Sen,
So-Yeon Kang,
Emaan Rashidi,
Devoja Ganguli,
Gerard F. Anderson,
G. Caleb Alexander
Publication year - 2021
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2021.0733
Subject(s) - copayment , medicine , pharmacy , medical prescription , payment , family medicine , formulary , liberian dollar , quitline , medical emergency , health care , finance , business , pharmacology , nursing , economics , intervention (counseling) , health insurance , economic growth
Despite ongoing debate regarding the high prices that patients pay for prescription drugs, to our knowledge, little is known regarding the use of coupons, vouchers, and other types of copayment "offsets" that reduce patients' out-of-pocket drug spending. Although offsets reduce patients' immediate cost burden, they may encourage the use of higher-cost products and diminish health insurers' ability to optimize pharmaceutical value.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom